디지털 치료법 복합부위 통증 증후군 시장 보고서(2026년)
Digital Therapeutics Complex Regional Pain Syndrome Global Market Report 2026
상품코드 : 1951713
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,745,000
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,750,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,755,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

디지털 치료제를 이용한 복합부위 통증 증후군(CRPS) 시장 규모는 최근 빠르게 확대하고 있습니다. 2025년 10억 5,000만 달러에서 2026년에는 12억 4,000만 달러로, CAGR 17.8%로 성장할 것으로 예상됩니다. 지난 수년간의 성장에는 CRPS 치료의 과제에 대한 인식 증가, 통증 관리에 있어 디지털 헬스 솔루션의 활용 증가, 원격의료 플랫폼의 수용 확대, 디지털 치료제의 조기 임상 검증, 비약물 요법에 대한 관심 증가 등이 주요 요인으로 작용한 것으로 보입니다.

디지털 치료제를 이용한 복합부위 통증 증후군(CRPS) 시장 규모는 향후 몇 년간 급속한 성장이 전망됩니다. 2030년에는 23억 6,000만 달러에 달하고, CAGR은 17.5%가 될 전망입니다. 예측 기간의 성장 요인으로는 처방전 디지털 치료제 도입 확대, 재택 통증 관리 솔루션에 대한 수요 증가, 의료진 지원형 디지털 케어 모델 확대, 웨어러블 모니터링 기기와의 연계 강화, 디지털 치료제에 대한 상환 지원 확대 등을 꼽을 수 있습니다. 예측 기간 동안 주요 동향으로는 소프트웨어 기반 통증 관리 프로그램 도입 확대, 원격 환자 모니터링 도구의 통합 발전, 맞춤형 치료 알고리즘 확대, 데이터 기반 증상 추적 플랫폼 사용 증가, 환자 참여 및 치료 순응도 향상에 대한 집중도 강화 등이 있습니다.

스마트폰과 인터넷 연결의 보급 확대는 향후 복합부위통증증후군을 위한 디지털 치료제 시장의 성장을 촉진할 것으로 예상됩니다. 스마트폰과 인터넷 연결은 인터넷에 접속할 수 있는 모바일 단말기를 의미하며, 사용자가 언제 어디서나 통신, 정보 검색, 온라인 서비스를 이용할 수 있게 해줍니다. 스마트폰과 인터넷 연결에 대한 접근성 확대는 급속한 도시화에 의해 촉진되고 있습니다. 인구가 밀집된 도시 지역에서는 인프라 수요와 경제적 여건이 조성되어 모바일 네트워크와 브로드밴드 서비스 구축이 가속화되고 있기 때문입니다. 스마트폰과 인터넷의 보급 확대는 접근 가능한 모바일 플랫폼을 통한 지속적인 환자 참여, 원격 모니터링, 개인화된 치료 제공을 가능하게함으로써 복합부위통증증후군을 위한 디지털 치료제의 성장을 뒷받침하고 있습니다. 이를 통해 치료 순응도 향상, 실시간 데이터 수집, 통증 관리의 종합적인 성과를 촉진할 수 있습니다. 예를 들어, 미국 정부 기관인 연방통신위원회(FCC)에 따르면, 2025년 5월 기준 2023년 6월부터 2024년 6월까지 총 접속 건수는 약 2.5% 증가하여 5억 4,900만 건에 달했습니다. 모바일 접속 건수는 전년 대비 2.5% 증가한 4억 1,600만 건(2024년 6월 기준), 고정 접속 건수는 2.3% 증가한 1억 3,300만 건을 기록했습니다. 따라서 스마트폰과 인터넷 연결에 대한 접근성 확대가 복합부위통증증후군용 디지털 치료제 시장의 성장을 촉진하고 있습니다.

향후 몇 년 동안 디지털 치료법을 이용한 복합부위통증증후군 시장의 성장은 의료비 지출 증가가 견인할 것으로 예상됩니다. 헬스케어 지출은 정부, 민간 보험사, 기업 및 개인이 의료 서비스, 치료, 의약품 및 관련 건강 활동에 지출하는 총 자금을 의미합니다. 만성질환의 유병률이 증가함에 따라 장기적인 의료 관리와 지속적인 치료 개입이 필요하기 때문에 의료비 지출은 증가 추세에 있습니다. 의료비 지출의 증가는 전통적인 대면 진료에 따른 지속적인 비용 부담 없이 접근이 용이하고 확장 가능한 통증 관리 솔루션을 제공하는 디지털 치료제와 같은 비용 효율적인 치료법에 대한 수요를 뒷받침하고 있습니다. 예를 들어, 미국 정부 기관인 메디케어-메디케이드 서비스 센터(CMS)에 따르면, 2025년 6월 기준 2023년 국민의료비(NHE)는 전년 대비 7.5% 증가한 4조 9,000억 달러로 1인당 평균 1만 4,570달러, 국내총생산(GDP)의 17.6%를 차지할 것으로 전망하고 있습니다. 메디케어 지출은 8.1% 증가한 1조298억 달러로 NHE 총 지출의 21%를 차지했습니다. 따라서 헬스케어 지출의 증가는 디지털 치료제를 이용한 복합부위통증증후군(CRPS) 시장의 성장을 촉진하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의가 공급망에 미치는 영향, 코로나가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장에서 세계의 총 잠재 시장 규모(TAM)

제9장 시장 세분화

제10장 지역별, 국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자 환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 인수합병

제40장 시장 잠재력이 높은 국가, 부문, 전략

제41장 부록

KSM
영문 목차

영문목차

Digital therapeutics for complex regional pain syndrome are scientifically validated software interventions provided via apps or online platforms that lead patients through proven therapies while monitoring symptoms and treatment adherence. Their goal is to alleviate pain and hypersensitivity, improve function and daily activities, and assist clinicians with remote monitoring and personalized care, aiming to reduce dependence on medications and frequent clinic appointments.

The main product types of digital therapeutics for complex regional pain syndrome include software, devices, and platforms. Software consists of a collection of programs and data that allow computers or devices to perform tasks, manage information, and interact effectively with users or other systems. These products are distributed through multiple channels, including online platforms, pharmacies, direct sales, and other distribution methods. They are applied in various areas, such as pain management, rehabilitation, patient education, and other purposes, and are utilized by a range of end-users, including hospitals, clinics, homecare settings, research institutes, and others.

Tariffs are impacting the digital therapeutics complex regional pain syndrome market by increasing costs associated with imported wearable devices, sensors, cloud infrastructure hardware, and specialized electronic components used in monitoring and feedback systems. Healthcare providers and digital health developers in North America and Europe are most affected due to reliance on imported hardware and technology infrastructure, while Asia-Pacific faces cost pressures in device manufacturing. These tariffs are increasing development and deployment costs for hybrid software-device solutions. However, they are also encouraging localized device production, domestic software innovation, and greater reliance on cloud-based platforms with reduced hardware dependency.

The digital therapeutics complex regional pain syndrome market research report is one of a series of new reports from The Business Research Company that provides digital therapeutics complex regional pain syndrome market statistics, including digital therapeutics complex regional pain syndrome industry global market size, regional shares, competitors with a digital therapeutics complex regional pain syndrome market share, detailed digital therapeutics complex regional pain syndrome market segments, market trends and opportunities, and any further data you may need to thrive in the digital therapeutics complex regional pain syndrome industry. This digital therapeutics complex regional pain syndrome market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The digital therapeutics complex regional pain syndrome market size has grown rapidly in recent years. It will grow from $1.05 billion in 2025 to $1.24 billion in 2026 at a compound annual growth rate (CAGR) of 17.8%. The growth in the historic period can be attributed to growing awareness of CRPS treatment gaps, rising use of digital health solutions in pain management, increased acceptance of telehealth platforms, early clinical validation of digital therapeutics, growing focus on non-pharmacological therapies.

The digital therapeutics complex regional pain syndrome market size is expected to see rapid growth in the next few years. It will grow to $2.36 billion in 2030 at a compound annual growth rate (CAGR) of 17.5%. The growth in the forecast period can be attributed to increasing adoption of prescription digital therapeutics, rising demand for home-based pain management solutions, expansion of clinician-supported digital care models, growing integration with wearable monitoring devices, increasing reimbursement support for digital therapeutics. Major trends in the forecast period include increasing adoption of software-based pain management programs, growing integration of remote patient monitoring tools, expansion of personalized therapy algorithms, rising use of data-driven symptom tracking platforms, enhanced focus on patient engagement and adherence.

The increasing availability of smartphones and internet connectivity is expected to drive the growth of the digital therapeutics complex regional pain syndrome market going forward. Smartphones and internet connectivity refer to mobile devices that provide access to the internet, allowing users to communicate, browse information, and utilize online services anytime and anywhere. The rising access to smartphones and internet connectivity is fueled by rapid urbanization, as densely populated urban areas create infrastructure needs and economic conditions that accelerate the rollout of mobile networks and broadband services. Greater smartphone and internet penetration supports the growth of digital therapeutics for complex regional pain syndrome by enabling continuous patient engagement, remote monitoring, and personalized therapy delivery through accessible mobile platforms, thereby enhancing treatment adherence, real-time data collection, and overall pain management outcomes. For example, in May 2025, according to the Federal Communications Commission, a US-based government agency, total connections increased by approximately 2.5% between June 2023 and June 2024, reaching 549 million. Mobile connections rose 2.5% year over year to 416 million as of June 2024, while fixed connections grew about 2.3% to 133 million over the same period. Therefore, increasing access to smartphones and internet connectivity is propelling the growth of the digital therapeutics complex regional pain syndrome market.

The increasing healthcare expenditure is expected to drive the growth of the digital therapeutics complex regional pain syndrome market in the coming years. Healthcare expenditure refers to the total financial resources spent by governments, private insurers, businesses, and individuals on medical services, treatments, medications, and related health activities. Healthcare spending is rising due to the growing prevalence of chronic diseases, which require long-term medical management and ongoing therapeutic interventions. Increasing healthcare expenditure supports the demand for cost-effective treatment options such as digital therapeutics, which provide accessible and scalable pain management solutions without the recurring costs associated with traditional in-person care. For example, in June 2025, according to the Centers for Medicare & Medicaid Services, a US government agency, national health expenditures (NHE) rose by 7.5% in 2023 to reach $4.9 trillion, averaging $14,570 per person and accounting for 17.6% of the Gross Domestic Product (GDP). Medicare spending increased by 8.1% to $1,029.8 billion, representing 21% of total NHE. Therefore, rising healthcare expenditure is fueling the growth of the digital therapeutics complex regional pain syndrome market.

In November 2023, BehaVR Inc., a US-based digital therapeutics company, merged with Fern Health to establish RealizedCare, a digital care management platform for chronic pain and mental health. Through this merger, BehaVR and Fern Health aim to develop a comprehensive digital care management platform that combines digital therapeutics with traditional support services to provide personalized, scalable, and value-based care for chronic pain and associated mental health conditions. Fern Health Inc. is a US-based digital health company that focuses on delivering virtual, evidence-based chronic pain management solutions.

Major companies operating in the digital therapeutics complex regional pain syndrome market are Abbott Laboratories, Hinge Health Inc., MedBridge Inc., Luna Innovations Inc., BioWave Inc., Kaia Health Software GmbH, XRHealth Inc., Vori Health Inc., AppliedVR Inc., Theranica Bio-Electronics Ltd., PainDrainer Inc., Physitrack Ltd., WellBrain Inc., Vitrue Health Inc., Upswing Health Inc., Flowly Inc., Plethy Inc., PainChek Ltd., Oska Wellness Inc., DarioHealth Corp.

North America was the largest region in the digital therapeutics complex regional pain syndrome market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital therapeutics complex regional pain syndrome market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the digital therapeutics complex regional pain syndrome market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The digital therapeutics for complex regional pain syndrome market consists of revenues earned by entities by providing services such as prescription digital therapeutic program delivery, virtual reality pain rehabilitation sessions, remote patient monitoring and analytics, tele coaching and behavioral therapy support, and clinician decision-support and care-plan personalization. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital therapeutics for complex regional pain syndrome market also includes sales of wearable sensors, monitoring devices, neurostimulation systems, and dorsal root ganglion stimulators. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Digital Therapeutics Complex Regional Pain Syndrome Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses digital therapeutics complex regional pain syndrome market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for digital therapeutics complex regional pain syndrome ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The digital therapeutics complex regional pain syndrome market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

2. Digital Therapeutics Complex Regional Pain Syndrome Market Characteristics

3. Digital Therapeutics Complex Regional Pain Syndrome Market Supply Chain Analysis

4. Global Digital Therapeutics Complex Regional Pain Syndrome Market Trends And Strategies

5. Digital Therapeutics Complex Regional Pain Syndrome Market Analysis Of End Use Industries

6. Digital Therapeutics Complex Regional Pain Syndrome Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Digital Therapeutics Complex Regional Pain Syndrome Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

8. Global Digital Therapeutics Complex Regional Pain Syndrome Total Addressable Market (TAM) Analysis for the Market

9. Digital Therapeutics Complex Regional Pain Syndrome Market Segmentation

10. Digital Therapeutics Complex Regional Pain Syndrome Market Regional And Country Analysis

11. Asia-Pacific Digital Therapeutics Complex Regional Pain Syndrome Market

12. China Digital Therapeutics Complex Regional Pain Syndrome Market

13. India Digital Therapeutics Complex Regional Pain Syndrome Market

14. Japan Digital Therapeutics Complex Regional Pain Syndrome Market

15. Australia Digital Therapeutics Complex Regional Pain Syndrome Market

16. Indonesia Digital Therapeutics Complex Regional Pain Syndrome Market

17. South Korea Digital Therapeutics Complex Regional Pain Syndrome Market

18. Taiwan Digital Therapeutics Complex Regional Pain Syndrome Market

19. South East Asia Digital Therapeutics Complex Regional Pain Syndrome Market

20. Western Europe Digital Therapeutics Complex Regional Pain Syndrome Market

21. UK Digital Therapeutics Complex Regional Pain Syndrome Market

22. Germany Digital Therapeutics Complex Regional Pain Syndrome Market

23. France Digital Therapeutics Complex Regional Pain Syndrome Market

24. Italy Digital Therapeutics Complex Regional Pain Syndrome Market

25. Spain Digital Therapeutics Complex Regional Pain Syndrome Market

26. Eastern Europe Digital Therapeutics Complex Regional Pain Syndrome Market

27. Russia Digital Therapeutics Complex Regional Pain Syndrome Market

28. North America Digital Therapeutics Complex Regional Pain Syndrome Market

29. USA Digital Therapeutics Complex Regional Pain Syndrome Market

30. Canada Digital Therapeutics Complex Regional Pain Syndrome Market

31. South America Digital Therapeutics Complex Regional Pain Syndrome Market

32. Brazil Digital Therapeutics Complex Regional Pain Syndrome Market

33. Middle East Digital Therapeutics Complex Regional Pain Syndrome Market

34. Africa Digital Therapeutics Complex Regional Pain Syndrome Market

35. Digital Therapeutics Complex Regional Pain Syndrome Market Regulatory and Investment Landscape

36. Digital Therapeutics Complex Regional Pain Syndrome Market Competitive Landscape And Company Profiles

37. Digital Therapeutics Complex Regional Pain Syndrome Market Other Major And Innovative Companies

38. Global Digital Therapeutics Complex Regional Pain Syndrome Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Digital Therapeutics Complex Regional Pain Syndrome Market

40. Digital Therapeutics Complex Regional Pain Syndrome Market High Potential Countries, Segments and Strategies

41. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기